Management of stage I and II nonsmall cell lung cancer

Keyphrases

• Radiotherapy 100%
• Adjuvant Chemotherapy 100%
• Randomized Trial 100%
• Targeted Therapy 100%
• Neoadjuvant Chemotherapy 100%
• Non-small Cell Lung Cancer (NSCLC) 100%
• Targeted Immunotherapy 100%
• High Risk 50%
• Local Treatment 50%
• Patient Selection 50%
• Aging Population 50%
• Resectable Disease 50%
• Lobectomy 50%
• Optimal Management 50%
• Therapeutic Modalities 50%
• High-risk Individuals 50%
• Stereotactic Body Radiation Therapy 50%
• Cardiopulmonary Risk 50%
• Minimally Invasive Technique 50%
• Interdisciplinary Collaboration 50%
• Early-stage Lung Cancer 50%
• Surgical Candidate 50%
• Complete Surgical Resection 50%
• Sublobar Resection 50%
• Conservative Resection 50%

INIS

• patients 100%
• cancer 100%
• management 100%
• lung cells 100%
• surgery 80%
• chemotherapy 80%
• risks 60%
• radiotherapy 60%
• therapy 40%
• immunotherapy 40%
• screening 20%
• diseases 20%
• data 20%
• yields 20%
• populations 20%
• aging 20%
• gold 20%

Medicine and Dentistry

• Lung Cancer 100%
• Neoadjuvant Chemotherapy 66%
• Targeted Therapy 66%
• Immunotherapy 66%
• Adjuvant Chemotherapy 66%
• Radiation Therapy 66%
• Minimally Invasive Procedure 33%
• Patient Selection 33%
• Local Therapy 33%
• Therapeutic Modality 33%
• Stereotactic Body Radiation Therapy 33%
• Lobectomy 33%
• Diseases 33%